stix expands from at-home pregnancy and ovulation tests to uti products with $3.5m seed
Addressing Women's Health Needs: Stix Secures $3.5 Million Seed Funding
Similar to how companies such as Ro and Hims have streamlined access to everyday health and wellness solutions for men, Stix is focused on doing the same for women.
Stix recently announced the completion of a $3.5 million seed funding round. This financing was jointly led by Resolute Ventures and SWAT Equity Partners, with additional investment from Entrepreneurs Roundtable Accelerator, Bullish, and several individual strategic investors.
To date, the company has raised a total of $5 million in funding.
Initial Focus and Expansion
Launched in 2019, Stix initially offered a direct-to-consumer (D2C) pregnancy test designed for ease of use and to reduce associated stigma. Traditional tests often employ imagery, like smiley faces, that may not resonate with all individuals undergoing testing.
The company subsequently broadened its product line to include ovulation tests and prenatal supplements.
Entering the UTI Diagnostics Market
Most recently, Stix has expanded into UTI diagnostic tests, alongside pain relief products and preventative supplements. This expansion into UTI solutions is particularly significant.
According to womenshealth.gov, women are 30 times more susceptible to UTIs than men, and over half of all women will experience at least one UTI during their lifetime. This represents a substantial market opportunity.
Furthermore, accessible over-the-counter diagnostic products for UTIs are limited. Obtaining a diagnosis often requires a doctor's visit, despite the prevalence of these infections.
Empowering Women with At-Home Testing
Stix’s FDA-cleared UTI test provides a convenient way for women to gain insights and take proactive steps from home. Products are offered through a subscription model, allowing customers to customize delivery frequency.
The Team Behind Stix
Stix was co-founded by Cynthia Plotch and Jamie Norwood. The company’s vision extends beyond products to encompass comprehensive educational resources and content.
The startup currently employs eight individuals, including the co-founders. Notably, three team members are people of color, and the entire team is comprised of women.
Competitive Landscape
Stix operates within a growing market. Companies like Modern Fertility also offer D2C ovulation and pregnancy tests, and have established distribution partnerships with major retailers such as Wal-Mart.
Jordan Crook
Jordan Crook's Role at TechCrunch
Jordan Crook previously held the position of Deputy Editor at TechCrunch. This role signified a key leadership position within the organization.
Responsibilities as Deputy Editor
As Deputy Editor, Crook was instrumental in overseeing the editorial direction of TechCrunch. He contributed significantly to the platform’s coverage of the technology industry.
His duties encompassed a wide range of tasks, including content curation and management. He also played a role in guiding the work of other journalists.
Background and Experience
Prior to his role as Deputy Editor, Jordan Crook gained extensive experience in technology journalism. This background equipped him with a deep understanding of the sector.
He consistently demonstrated a keen eye for emerging trends and insightful analysis. This made him a valuable asset to the TechCrunch team.
Impact on TechCrunch
Crook’s contributions helped to maintain TechCrunch’s reputation as a leading source of technology news. His leadership was crucial in shaping the platform’s voice.
He was known for his ability to identify and cultivate talented writers. This ensured the continued quality of TechCrunch’s reporting.
Further Information
Details regarding his current endeavors following his departure from TechCrunch are publicly available through various professional networking platforms. Jordan Crook remains a prominent figure in the tech media landscape.